References
- Ahmed SA, Gogal RM, Walsh JE. (1994). A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H]thymidine incorporation assay. J Immunol Meth, 170, 211–24
- Alajez NM, Schmielau J, Alter MD, et al. (2005). Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution. Blood, 105, 4583–9
- Arya R, Rolan PE, Wootton R, et al. (1996). Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia. Brit J Haematol, 93, 817–21
- Barnd DL, Lan MS, Metzgar RS, Finn OJ. (1989). Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA, 86, 7159–63
- Burchell J, Gendler S, Taylor-Papadimitriou J, et al. (1987). Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res, 47, 5476–82
- Chen H, Hall S, Heffernan B, et al. (1997). Convergence of Schiff base costimulatory signaling and TCR signaling at the level of mitogen-activated protein kinase ERK2. J Immunol, 159, 2274–81
- Clerici M, Cogliati M, Rizzardini G, et al. (2000). In vitro immunomodulatory properties of tucaresol in HIV infection. In: Clin Immunol. San Diego, CA: Academic Press, 97, 211–20
- Gendler S, Taylor-Papadimitriou J, Duhig T, et al. (1988). A highly immunogenic region of a polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem, 263, 12820–3
- Hall SR, Rhodes J. (2001). Schiff base-mediated co-stimulation primes the T-cell-receptor-dependent calcium signalling pathway in CD4 T cells. Immunology, 104, 50–7
- Jost LM, Kirkwood JM, Whiteside TL. (1992). Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Meth, 147, 153–65
- Kanof ME, Smith PD. (1994). Preparation of human mononuclear cell populations and subpopulations. In: Coligan JE, ed. Current Protocols in Immunology. New York: John Wiley & Sons, 7
- Kornbluth J, Flomenberg N, Dupont B. (1982). Cell surface phenotype of a cloned line of natural killer cells. J Immunol, 129, 2831–7
- Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth, 65, 55–63
- Page S, Fischer C, Baumgartner B, et al. (1999). 4-hydroxynonenal prevents NF-κB activation and tumor necrosis factor expression by inhibiting IκB phosphorylation and subsequent proteolysis. J Biol Chem, 274, 11611–8
- Rhodes J. (1996). Covalent chemical events in immune induction: Fundamental and therapeutic aspects. Immunol Today, 17, 436–41
- Rhodes J. (2002). Discovery of immunopotentiatory drugs: Current and future strategies. Clin Exp Immunol, 130, 363–9
- Rhodes J, Chen H, Hall SR. (1995). Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature, 377, 71–5
- Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. (1991). An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Meth, 142, 257–65
- von Zons P, Crowley-Nowick P, Friberg D, et al. (1997). Comparison of europium and chromium release assays: Cytotoxicity in healthy individuals and patients with cervical carcinoma. Clin Diagn Lab Immunol, 4, 202–7
- Wright SE. (2012). Immunotherapy of breast cancer. Expert Opin Biol Ther, 12, 479–90
- Wright SE, Khaznadar R, Wang Z, et al. (2008a). Generation of MUC1-stimulated mononuclear cells using optimized conditions. Scand J Immunol, 67, 24–9
- Wright SE, Kilinski L, Talib S, et al. (2000). Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site. J Immunother, 23, 2–10
- Wright SE, Rewers-Felkins KA, Quinlin IS, et al. (2002). Adoptive immunotherapy of mucin1 expressing adenocarcinomas with mucin1 stimulated human peripheral blood mononuclear cells. Int J Mol Med, 9, 401–4
- Wright SE, Rewers-Felkins KA, Quinlin IS, et al. (2008b). MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells. Immunol Invest, 37, 215–25